Internet Live Courses

Register

Details

Nineteenth Annual Pediatric Endocrinology and Diabetes Symposium
Monday, November 9, 2020, 8:30 AM - 12:30 PM
Online

Target Audience:
Credits: AMA PRA Category 1 Credits™ (3.25 hours), Non-Physician Attendance (3.25 hours)

This symposium is specifically designed to give a state of the art update on selected topics in Pediatric Endocrinology including Growth Hormone and Diabetes.

Register

Details

17th Annual Mount Sinai Inflammatory Bowel Disease Consultant's Course: Challenges and Insights in a New Era of IBD Management
Tuesday, November 10, 2020, 5:00 PM - Tuesday, November 17, 2020, 7:30 PM
Online

Target Audience:
Credits: AMA PRA Category 1 Credits™ (5.00 hours), Non-Physician Attendance (5.00 hours)

The 17th Annual Mount Sinai Inflammatory Bowel Disease Consultant's Internet Live Course will provide an in-depth review of IBD therapies, treatment strategies and patient management. Icahn School of Medicine at Mount Sinai faculty will lend their expertise in this virtual Q&A webinar. 

Register

Details

Frontline Excellence in Ambulatory Chronic Disease Management Module 1: CHF and Diabetes
Wednesday, November 11, 2020, 6:00 PM - 7:30 PM
Online

Target Audience:
Credits: AMA PRA Category 1 Credits™ (1.50 hours), Non-Physician Attendance (1.50 hours)

Focus on successfully managing disease in the ambulatory setting--classification, medication management and multi-disciplinary collaboration.

Register

Details

7th Annual Advances in Neurology: Diagnosis and Practical Management of Patients with Nervous System Disorders
Saturday, November 21, 2020, 8:15 AM - 5:00 PM
Online

Target Audience:
Credits: AMA PRA Category 1 Credits™ (6.75 hours), Non-Physician Attendance (6.75 hours)

The 7th Annual Advances in Neurology is a full-day virtual CME event that will provide clinicians with an update on diagnostic processes, cutting-edge technologies, and innovative management strategies in these 8 areas of neurology: headache, movement disorders and deep brain stimulation, epilepsy, neurological manifestations of COVID-19, stroke, multiple sclerosis, neuromuscular disease, physician-patient communication. Through didactic lecture, case presentations, and interactive discussions with expert clinicians, attendees will be better enabled to diagnose and manage patients living with neurologic disorders in 2020 and beyond. Patient simulators will interact with faculty to provide an enhanced learning experience for participants.

Register

Details

23rd Annual Mount Sinai Winter Symposium “Advances in Medical and Surgical Dermatology”
Friday, December 4, 2020, 7:00 AM - Sunday, December 6, 2020, 6:00 PM
Online

Target Audience:
Credits: AMA PRA Category 1 Credits™ (19.25 hours), Non-Physician Attendance (19.25 hours)

Register

Details

Advances in Pediatric Food Allergy: From Prevention to Treatment and Everything in Between
Saturday, December 5, 2020, 10:00 AM - 3:00 PM
Online

Target Audience:
Credits: AMA PRA Category 1 Credits™ (4.50 hours), Non-Physician Attendance (4.50 hours)

This half-day virtual course is designed to provide allergists, generalists, and allied health, with updated information on strategies for prevention, diagnosis, and treatment of food allergies. Lectures will highlight recent publications from the last year.

Register

Details

NY Transcatheter Valves
Thursday, December 10, 2020, 8:00 AM - 1:40 PM
Online

Target Audience:
Credits: AMA PRA Category 1 Credits™ (7.00 hours)

Full day virtual course with lectures and 2 live cases broadcast from the Cath Lab.

Register

Details

Mount Sinai Liver Cancer Program. 15th Anniversary. “Liver Cancer: Advances in Science and Clinical Management
Friday, December 11, 2020, 8:30 AM - 5:00 PM
Online

Target Audience:
Credits: AMA PRA Category 1 Credits™ (7.00 hours)

This conference will assemble multidisciplinary experts on chronic liver diseases, hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) from the Mount Sinai Liver Cancer Program and one outstanding invited lecturer. The meeting is intended to provide a summary of the state-of ¬the-art knowledge of the novel advancements reported in 2020 on the pathogenesis and clinical management of liver cancer, including the research conducted in Mount Sinai.